# Abtis Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/abtis-co

- Industry: Biotechnology
- Headquarters: Suwon, South Korea
- Website: www.abtis.co.kr
- Total disclosed funding: $18M
- Latest round: Series B (Feb 1, 2021)
- Investors on record: 10

## About

Based in South Korea, and founded in 2016, AbTis operates as a biotech company specializing in the development of Antibody-Drug Conjugate(ADC). In 2016, it established a corporate research institute. In 2019, it selected Korea-Canada International joint technology development project. In November 2023, Abtis Co., Ltd. raised an undisclosed amount in venture funding from new investor Dong-A ST Co., Ltd. Following the transaction, Dong-A ST Co., Ltd. will hold 51% majority stake of the company. 


The company's pipelines are designed to enhance the safety and efficacy of the current antibody-drug conjugates, which apply to the native antibodies, commercial antibodies, or novel antibodies under development.

## Funding rounds

- Series B, Feb 1, 2021, $13M — AJU IB Investment, CKD Venture Capital, KDB Capital, K2 Investment Partners, Time Folio Asset Management, Prodigy Investment, Kingo Investment Partners, Stonebridge Ventures
- Series A, Jun 12, 2018, $4.7M — Stonebridge Capital, K2 Investment Partners, JX Partners

## Investors

- Stonebridge Capital (https://capitalatlas.ai/funds/stonebridge-capital) — Series A
- K2 Investment Partners (https://capitalatlas.ai/funds/k2-investment-partners) — Series A, Series B
- JX Partners (https://capitalatlas.ai/funds/jx-partners) — Series A
- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series B
- CKD Venture Capital (https://capitalatlas.ai/funds/ckd-venture-capital) — Series B
- KDB Capital (https://capitalatlas.ai/funds/kdb-capital) — Series B
- Time Folio Asset Management — Series B
- Prodigy Investment (https://capitalatlas.ai/funds/prodigy-investment) — Series B
- Kingo Investment Partners (https://capitalatlas.ai/funds/kingo-investment-partners) — Series B
- Stonebridge Ventures — Series B